Additionally, regulatory RNAs—particularly miRNAs—are capable of targeting multiple nodes within the TGF-β signaling, including ligands, receptors (e.g., TGFBR1/2), intracellular SMADs, and downstream effectors, adding further complexity to its role in glioma biology [23]. The gene discussed is TGFB1; the disease is central nervous system cancer.